PROVECTUS BIOPHARMACEUTICALS, INC.
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2020 | $-0.02 | $-0.11 |
| FY2021 | $-0.01 | $-0.10 |
| FY2022 | $-0.01 | $-0.09 |
| FY2023 | $-0.01 | $-0.06 |
| FY2024 | $-0.01 | $-0.05 |
EPS
| Fiscal Year | EPS | Cyclically Adjusted EPS |
|---|---|---|
| FY2020 | $-0.02 | $-0.11 |
| FY2021 | $-0.01 | $-0.10 |
| FY2022 | $-0.01 | $-0.09 |
| FY2023 | $-0.01 | $-0.06 |
| FY2024 | $-0.01 | $-0.05 |